NCLAT: Cannot Withhold Income Tax Refund Received by Bank During CIRP In CD's Account  ||  All. HC: With S. 111 of BNS Covering 'Organised Crime' It Appears Gangsters Act has become Redundant  ||  P&H HC: Cannot Allow Changes in Admission Form after Submission  ||  Bom. HC: Findings in Criminal Proceedings Cannot Be Relied Upon While Adjudicating Civil Proceedings  ||  P&H HC Directs Jail Authorities to Decide Parole Applications within Four Months  ||  Allahabad HC: Merely Supporting Pakistan Will Not Prima Facie Attract Section 152 of BNS  ||  HP HC Upholds Wife’s Claim of Adverse Possession after Husband’s Death  ||  Patna HC: Maintenance may be Allowed in Disputed Marriages if Relationship Was Socially Accepted  ||  Karnataka HC: State to Respond in 3 Weeks regarding Mandatory Teaching of Kannada  ||  Delhi HC: Husband Unhappy in Marriage is No Proof of Abetment of Suicide    

Search Results for Tag : Natco Pharma

News

U.S. PTO Rules in Favour of Mylan(29.08.2016)

U.S.Patent and Trademark Office (PTO) has ruled in the favour of Natco Pharma’s marketing partner Mylan, with regard to patent claims pertaining to mu.....

Tags : U.S.Patent and Trademark Office, Natco Pharma, patent claims



Delhi High Court Awards Natco Pharma Interim Relief in BMS Patents Case(23.07.2019)

Delhi High Court has awarded interim relief to the Hyderabad-based Natco Pharma Ltd in a fresh patents battle, with the court setting aside an injunc.....

Tags : Delhi High Court, Natco Pharma



Celgene Settles Revlimid Patent Dispute with Natco Pharma(24.12.2015)

Natco Pharma Ltd and partner Allergan Plc has settled dispute with US-based drug maker Celgene Corp. in the patent infringement case of the latter’s c.....

Tags : Natco Pharma, Celgene Corp, Revlimid Patent



Natco Settles Patent Dispute with Gilead in a US Court(15.12.2015)

Natco Pharma along with its partner Alvogen has settled the patent infringement suit with Gilead Sciences Inc. and others over “Tamiflu” in a US court.....

Tags : Natco Pharma , Alvogen, Tamiflu, Patent Dispute



Disclaimer | Copyright 2025 - All Rights Reserved